On Jul 26, 2021 Embark closed a Series B round and raised $75,000,000 from F-Prime Capital, Freestyle Capital, Slow Ventures, SoftBank Vision Fund, SV Angel, Third Kind Venture Capital, the round led by SoftBank Vision Fund.
About the company: Embark is located in Boston, Massachusetts, United States. “The highest-rated, most accurate dog DNA test available, Embark provides insights on breed, health, ancestry, and more with a simple cheek swab.” Embark’s dog DNA test retails for $199 and enables dog owners, breeders and veterinarians to personalize care plans based on a dog’s unique genetic profile. It can test for over 350 breeds and 200 genetic health risks, as well as physical traits. Similar to a 23andMe test, test users can learn characteristics about breed, health and ancestry. According to the company, the round was “the biggest Series B for a pet startup to date.”
Company website: embarkvet.com